mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.034 |
0.8 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |